Cayman Pharma S.R.O. Company Profile - Czech Republic | Financials & Key Executives

Cayman Pharma S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing

Secondary Activities: All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Testing Laboratories | Management Consulting Services | All Other Business Support Services

Full name: Cayman Pharma S.R.O.

Profile Updated: October 18, 2025

Cayman Pharma S.R.O. is a company in Czech Republic, with a head office in Neratovice. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on December 17, 2001. It currently has a total number of 100 - 199 (2023) employees. From the latest financial highlights, Cayman Pharma S.R.O. reported a net sales revenue drop of 15.69% in 2024. Its’ total assets recorded a negative growth of 6.33%. The net profit margin of Cayman Pharma S.R.O. decreased by 6.16% in 2024.

Headquarters
Prace 657
Neratovice; Stredocesky; Postal Code: 27711

Contact Details: Purchase the Cayman Pharma S.R.O. report to view the information.

Website: http://www.nerapharm.cz

Basic Information

Total Employees:

Purchase the Cayman Pharma S.R.O. report to view the information.

Registered Capital:

Purchase the Cayman Pharma S.R.O. report to view the information.

Financial Auditors:

Purchase the Cayman Pharma S.R.O. report to view the information.

Incorporation Date:

December 17, 2001

Key Executives

Purchase this report to view the information.

Legal Representative

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Cayman Pharma S.R.O. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.

Net sales revenue

-15.69%▼

Total operating revenue

-15.68%▼

Operating profit (EBIT)

-42.44%▼

EBITDA

-39.99%▼

Net Profit (Loss) for the Period

-40.37%▼

Total assets

-6.33%▼

Total equity

-4.86%▼

Operating Profit Margin (ROS)

-7.89%▼

Net Profit Margin

-6.16%▼

Return on Equity (ROE)

-6.08%▼

Quick Ratio

-0.05%▼

Cash Ratio

1.7%▲

Similar companies

Related EMIS Industry Reports